| pubmed-article:21425146 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21425146 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21425146 | lifeskim:mentions | umls-concept:C0007137 | lld:lifeskim |
| pubmed-article:21425146 | lifeskim:mentions | umls-concept:C0460004 | lld:lifeskim |
| pubmed-article:21425146 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:21425146 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:21425146 | lifeskim:mentions | umls-concept:C0025723 | lld:lifeskim |
| pubmed-article:21425146 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
| pubmed-article:21425146 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:21425146 | pubmed:dateCreated | 2011-3-22 | lld:pubmed |
| pubmed-article:21425146 | pubmed:abstractText | The overall 5-year survival rate of approximately 60% for head and neck cancer patients has remained essentially unchanged over the past 30 years. MicroRNA-137 (miR-137) plays an essential role in cell-cycle control at the G1/S-phase checkpoint. However, the aberrant miR-137 promoter methylation observed in squamous cell carcinoma of the head and neck (SCCHN) suggests a tumor-specific molecular defect that may contribute to disease progression. | lld:pubmed |
| pubmed-article:21425146 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21425146 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21425146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21425146 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21425146 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21425146 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:TaioliEmanuel... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:SobolRobert... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:BunkerClarean... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:GrandisJennif... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:StoneRoslyn... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:SeethalaRaja... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:KellyLoriL | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:Lyons-WeilerM... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:LangevinScott... | lld:pubmed |
| pubmed-article:21425146 | pubmed:author | pubmed-author:LaframboiseWi... | lld:pubmed |
| pubmed-article:21425146 | pubmed:copyrightInfo | Copyright © 2010 American Cancer Society. | lld:pubmed |
| pubmed-article:21425146 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21425146 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:21425146 | pubmed:volume | 117 | lld:pubmed |
| pubmed-article:21425146 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21425146 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21425146 | pubmed:pagination | 1454-62 | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:meshHeading | pubmed-meshheading:21425146... | lld:pubmed |
| pubmed-article:21425146 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21425146 | pubmed:articleTitle | MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. | lld:pubmed |
| pubmed-article:21425146 | pubmed:affiliation | University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, Pennsylvania 15213-1863, USA. | lld:pubmed |
| pubmed-article:21425146 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21425146 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:406928 | entrezgene:pubmed | pubmed-article:21425146 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21425146 | lld:entrezgene |
